Dilip Sanghvi is an established businessman, and one of the richest men in India. His company, Sun Pharma, is the world’s fifth-largest producer of generic drugs and the largest drug manufacturer in India.
Sun Pharma is looking to shape the future of the world drug industry. Sun established a new research division called Sparc in 2017, with 4 new drugs and 2 pieces of research in the pipeline.
The aim of the research division is to come up with the cheapest possible solution to everyday health problems such as the common cold or indigestion, along with improving the quality and decreasing the cost of anti-histamines and asthma medications.